143 related articles for article (PubMed ID: 26327232)
1. The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review.
Gaertner J; Weingärtner V; Lange S; Hausner E; Gerhardus A; Simon ST; Voltz R; Becker G; Schmacke N
PLoS One; 2015; 10(9):e0136640. PubMed ID: 26327232
[TBL] [Abstract][Full Text] [Related]
2. Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.
Weingärtner V; Dargatz N; Weber C; Mueller D; Stock S; Voltz R; Gaertner J
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):821-9. PubMed ID: 26959869
[TBL] [Abstract][Full Text] [Related]
3. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
[TBL] [Abstract][Full Text] [Related]
4. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Health-Related Quality of Life Reporting in Phase III RCTs of Advanced Genitourinary Tumors.
Di Costanzo F; Napolitano F; Salomone F; Amato AR; Alberico G; Migliaccio F; Pecoraro G; Marra A; Crocetto F; Ruffo A; Scagliarini S; Rossetti S; Puglia L; Di Napoli M; Bianco R; Servetto A; Formisano L
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067406
[TBL] [Abstract][Full Text] [Related]
6. Methodological management of end-of-life decision data in intensive care studies: A systematic review of 178 randomized control trials published in seven major journals.
Kerever S; Jacquens A; Smail-Faugeron V; Gayat E; Resche-Rigon M
PLoS One; 2019; 14(5):e0217134. PubMed ID: 31136601
[TBL] [Abstract][Full Text] [Related]
7. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Efficace F; Bottomley A; Osoba D; Gotay C; Flechtner H; D'haese S; Zurlo A
J Clin Oncol; 2003 Sep; 21(18):3502-11. PubMed ID: 12972527
[TBL] [Abstract][Full Text] [Related]
8. Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.
Adamowicz K
Qual Life Res; 2017 Apr; 26(4):813-822. PubMed ID: 27738867
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: Problems with Russian Publications.
Verbitskaya EV
Int J Risk Saf Med; 2015; 27 Suppl 1():S89-90. PubMed ID: 26639728
[TBL] [Abstract][Full Text] [Related]
10. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M
Ann Oncol; 2018 Dec; 29(12):2288-2295. PubMed ID: 30304498
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations.
Kvam AK; Fayers P; Hjermstad M; Gulbrandsen N; Wisloff F
Eur J Haematol; 2009 Oct; 83(4):279-89. PubMed ID: 19558508
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.
Claassens L; van Meerbeeck J; Coens C; Quinten C; Ghislain I; Sloan EK; Wang XS; Velikova G; Bottomley A
J Clin Oncol; 2011 May; 29(15):2104-20. PubMed ID: 21464420
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic review.
Sparano F; Aaronson NK; Sprangers MAG; Fayers P; Pusic A; Kieffer JM; Cottone F; Rees J; Pezold M; Anota A; Charton E; Vignetti M; Wan C; Blazeby J; Efficace F
BMJ Support Palliat Care; 2019 Dec; 9(4):451-463. PubMed ID: 31719051
[TBL] [Abstract][Full Text] [Related]
14. Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018.
Reale ML; De Luca E; Lombardi P; Marandino L; Zichi C; Pignataro D; Ghisoni E; Di Stefano RF; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Bironzo P; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Lung Cancer; 2020 Jan; 139():47-54. PubMed ID: 31734586
[TBL] [Abstract][Full Text] [Related]
15. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
Efficace F; Osoba D; Gotay C; Sprangers M; Coens C; Bottomley A
Ann Oncol; 2007 Apr; 18(4):775-81. PubMed ID: 17259641
[TBL] [Abstract][Full Text] [Related]
16. Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.
St Germain D; Denicoff A; Torres A; Kelaghan J; McCaskill-Stevens W; Mishkin G; O'Mara A; Minasian LM
Cancer; 2020 Jun; 126(11):2687-2693. PubMed ID: 32237256
[TBL] [Abstract][Full Text] [Related]
17. Quality of evidence in a post-Soviet country: evaluation of methodological quality of controlled clinical trials published in national journals from Uzbekistan.
Aripov T; Aniyozova D; Gorbunova I
BMC Med Res Methodol; 2020 Jul; 20(1):189. PubMed ID: 32660442
[TBL] [Abstract][Full Text] [Related]
18. Justification and reporting of subgroup analyses were lacking or inadequate in randomized controlled trials.
Fan J; Song F; Bachmann MO
J Clin Epidemiol; 2019 Apr; 108():17-25. PubMed ID: 30557676
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer.
Joly F; Vardy J; Pintilie M; Tannock IF
Ann Oncol; 2007 Dec; 18(12):1935-42. PubMed ID: 17698837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
